Wren Therapeutics raises £12.4m in latest financing round
Biopharma company has raised approximately £33m to date
26th January 2021
Latest news
Roche’s faricimab hits primary endpoint in wet AMD studies
Bispecific antibody met non-inferiority measure compared to Regeneron's Eylea
26th January 2021
AbbVie's Rinvoq bags two new EU approvals
Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis
26th January 2021
Moderna says its COVID-19 vaccine works effectively against variants
Lab tests evaluated vaccine's efficacy against UK and South African variants
26th January 2021
PharmaTimes confirms INTCR 2021 virtual finals days
The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually.
25th January 2021
Calquence tops Imbruvica in chronic lymphocytic leukaemia study
BTK inhibitor demonstrated non-inferior progression-free survival compared to Imbruvica
25th January 2021
NHS COVID-19 vaccination drive bolstered by new centres
Over 30 new vaccination centres open across England
25th January 2021
Psychiatry Consortium funds project investigating new schizophrenia treatments
Project will see the University of Oxford partner with the Earlham Institute, Biogen and Boehringer Ingelheim
25th January 2021
EU approval for Bavencio in bladder cancer
Approved for the maintenance treatment of advanced urothelial carcinoma
25th January 2021
Servier and MiNA Therapeutics ink neurology pact
Companies will develop saRNA therapies to treat neurological diseases
22nd January 2021
US green light for long-acting HIV regimen Cabenuva
Cabenuva consists of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine
22nd January 2021
Gilead's Veklury should be effective against COVID-19 variants
Company has completed genetic analysis for UK and South African variants
22nd January 2021
NICE no for BMS’ multiple sclerosis drug Zeposia
Cost-effectiveness estimates 'uncertain', according to NICE
22nd January 2021
US approval for MSD’s heart failure med Verquvo
Drug approved to reduce the risk of cardiovascular death/heart failure hospitalisation
21st January 2021
RCP survey finds over 1 in 4 doctors sought mental health support during pandemic
Large number of respondents reported feeling tired or exhausted
21st January 2021
